Details

Autor(en) / Beteiligte

• Hamed, Kamal
• Wiktorowicz, Tatiana
• Assadi Gehr, Maziar

Titel

No Evidence for Ceftobiprole-Induced Immune Hemolytic Anemia in Three Phase 3 Clinical Trials [Erratum]

Ist Teil von

• Infection and drug resistance, 2020-10, Vol.13, p.3461-3462

Ort / Verlag

Macclesfield: Taylor & Francis Ltd

Erscheinungsjahr

2020

Quelle

Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals

Beschreibungen/Notizen

• Hamed K, Wiktorowicz T, Assadi Gehr M. Infect DrugResist. 2020;13:3209- 3215. The authors have advised that the Funding statement wasmissing on page 3214 of the published paper. This errorwas introduced by the Editorial staff during the publicationprocess. The funding statement should read as follows: FundingThe TARGET and ERADICATE trials were supportedin part with federal funds from the Department ofHealth and Human Services, Office of the AssistantSecretary for Preparedness and Response, BiomedicalAdvanced Research and Development Authority, underContract No. HHSO100201600002C; and in part byBasilea Pharmaceutica International Ltd., Basel,Switzerland. BPR-PIP-002 trial was funded byBasilea Pharmaceutica International Ltd., Basel,Switzerland. Read the original article